Author

M. Naveed

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Meta-analysis Open access Sep 2026

Efficacy and safety of orforglipron 12 mg versus orforglipron 36 mg maintenance dose among patients with obesity with or without diabetes: a systematic review and comprehensive meta-analysis

Obesity is projected to affect about one billion adults by 2030 and is associated with cardiometabolic morbidity. Orforglipron is an oral, non-peptide glucagon-like peptide-1 receptor agonist developed to provide weight and metabolic benefits. Prior meta-analyses have supported its efficacy and safety but were limited...

Mohamed Gamal Hegaz, Mohammad Yassin Al Aboud, Abanoub I. I. Kamel et al. · BMC Endocrine Disorders · 0 citations

Review Sep 2026

Efficacy and Safety of Baxdrostat in Hypertension: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.

BACKGROUND Baxdrostat, a selective aldosterone synthase inhibitor, has emerged as a novel therapy for uncontrolled or resistant hypertension; however, randomized controlled trials (RCTs) have shown variable results. OBJECTIVE To evaluate the efficacy and safety of baxdrostat compared with placebo or standard care in...

Muhammad Burhan, Z. Shahid, M. Naveed et al. · The Annals of Pharmacotherap... · 0 citations

Aug 2026

Impact of Type 2 Diabetes Mellitus on Outcomes Following Transcatheter Aortic Valve Replacement: Insights From a Contemporary US Database.

Patients with T2DM undergoing TAVR demonstrate higher risks of all‐cause mortality, MACCE, and HF exacerbation compared to their counterparts without T2DM. The T2DM cohort also demonstrated higher all‐cause readmissions, mechanical ventilation, and renal replacement therapy compared to patients without T2D...

Hritvik Jain, Nandan Patel, M. Naveed et al. · Catheterization and cardiova... · 0 citations